A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Irritable Bowel SyndromeColonic DiseasesDiarrheaGastrointestinal Disease
Interventions
DRUG

crofelemer

Trial Locations (29)

14534

Tobey Village Office Park, Pittsford

18960

Grandview Medical Research, Inc, Sellersville

20010

Washington Gastroenterology, Washington D.C.

27103

Piedmont Medical Research Assoc., Inc., Winston-Salem

27403

LeBauer Research Associates, PA, Greensboro

27408

Medoff Medical / Vital Research, Greensboro

28401

Hanover Medical Specialists, PA, Wilmington

29621

Anderson Gastroenterology, Anderson

32720

University Clinical Research DeLand, DeLand

33426

Consultants for Clinical Research of South Florida, Boynton Beach

35801

Clinical Research Associates, Huntsville

37404

ClinSearch, Chattanooga

37620

TriCities Medical Research, Bristol

38120

Memphis Gastroenterology, Memphis

38301

Jackson Clinic, Jackson

39202

CRC of Jakson, Jackson

43212

Radient Research, Columbus

45219

Consultants for Clinical Research, Cincinnati

48602

Synergy Medical Education Alliance, Saginaw

61602

nTouch Research, Peoria

63141

Mercy Medical Group, St Louis

72117

Arkansas Gastroenterology, North Little Rock

75231

Radiant Research Dallas-North, Dallas

85225

Radiant Research Phoenix Southeast, Chandler

92120

Institute of Healthcare Assessment, Inc., San Diego

92801

AGMG Clinical Research Institute, Anaheim

92868

Community Clinical Trials, Orange

92869

AGMG Clinical Research, Orange

98405

Tacoma Digestive Disease Research Center, Tacoma

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00101725 - A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter